Cargando…
Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers
BACKGROUND: Early detection screening of asymptomatic populations for low prevalence cancers requires a highly specific test in order to limit the cost and anxiety produced by falsely positive identifications. Most solid cancers are a heterogeneous collection of diseases as they develop from various...
Autores principales: | Firpo, Matthew A, Boucher, Kenneth M, Mulvihill, Sean J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137269/ https://www.ncbi.nlm.nih.gov/pubmed/25096727 http://dx.doi.org/10.1186/1742-4682-11-34 |
Ejemplares similares
-
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
por: Firpo, Matthew A., et al.
Publicado: (2023) -
Biomarkers in pancreatic adenocarcinoma: current perspectives
por: Swords, Douglas S, et al.
Publicado: (2016) -
A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer
por: Daniel, Rhonda, et al.
Publicado: (2017) -
Diagnostic model for pancreatic cancer using a multi-biomarker panel
por: Choi, Yoo Jin, et al.
Publicado: (2021) -
MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer
por: Zhang, Shiyu, et al.
Publicado: (2021)